ICON DENTAL STUDIO INTRODUCES NEW TECHNOLOGY FOR TMJ RELIEF AND ANTI-AGING
TMJ disorders affect millions of Americans and can cause jaw pain, headaches, clenching, difficulty chewing and chronic facial tension. Unlike injectables that temporarily relax muscles, Emface offers a noninvasive option designed to improve muscle function while relieving TMJ-related discomfort.
Dr. Pratiti Gandhi, founder of
"Many patients come to us because they're struggling with jaw pain, teeth grinding or chronic facial tension," said Gandhi. "Emface gives us a way to help with TMJ symptoms while also naturally lifting and toning the face, and it does all this without needles. It's a great example of how modern dentistry can support overall head and neck health – not just healthy teeth."
The practice is also introducing Exion, an ultrasound treatment that boosts the skin's natural collagen production, reducing fine lines and producing hyaluronic acid for a "dewier" look.
Emface is sometimes called a "noninvasive facelift." It uses radiofrequency and muscle stimulation to firm skin, soften wrinkles and tone the muscles of the face. Exion works alongside it, using radiofrequency and ultrasound to encourage the skin's own renewal process.
To celebrate the launch of Emface and Exion,
View original content to download multimedia:https://www.prnewswire.com/news-releases/icon-dental-studio-introduces-new-technology-for-tmj-relief-and-anti-aging-302842266.html
SOURCE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Over 12,000 eggs protected: Grupo Sunset World and Sunset Royal celebrate the success of their 2026 Sea Turtle Protection Program
- Bybit Strengthens Security Defences Against Evolving Crypto Threats, Intercepting $700 Million in Potential User Losses
- Greenberg Traurig Advises SL Green on $312.2M Sale of Midtown Manhattan Office Property
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share